你即將離開本站

並前往https://markets.businessinsider.com/news/stocks/lilly-s-diabetes-drug-candidate-tirzepatide-meets-primary-study-outcome-in-surpass-4-trial-1030450418

Lilly's Diabetes Drug Candidate Tirzepatide Meets Primary ...

Results from the Surpass-4 study showed that treatment with ... a new class of medicines being studied for the treatment of type 2 diabetes.

確定！ 回上一頁

查詢 「SURPASS study」的人也找了：

  1. SURPASS study
    2.
  2. Tirzepatide
    3.
  3. SURPASS-3 tirzepatide
    4.
  4. SURPASS 4 tirzepatide
    5.
  5. Tirzepatide lancet
    6.
  6. Tirzepatide a potential new agent for type 2 diabetes
    7.
  7. SURPASS-CVOT
    8.
  8. Tirzepatide FDA
    9.